A professional news service dedicated to publishing up-to date-information regarding infection causing agents, anti-infective products and therapies.
Roberts RR et al. – The attributable medical and societal costs of ARI are considerable. Data from this analysis could form the basis for a more comprehensive evaluation of the cost of resistance and the potential economic benefits of prevention programs. read more
Pillai SK et al. – Clinicians should recognize that reduced vancomycin susceptibility can occur in S. aureus irrespective of background methicillin susceptibility and that development of intermediate vancomycin susceptibility in MSSA may result in increased tolerance to several classes of anti–staphylococcal antibiotics.
read more
acconelli E et al. – Colonizing and infecting strains from single patients were genotypically identical. Identifying ARB colonization early during antibiotic therapy could target a high–risk hospitalized population that may benefit from intervention to decrease the risk of subsequent nosocomial infections. read more
Super-Bug News is available free of charge. Sign Up today and get your password for unrestricted use.
